Neurocrine Bioscience buy Wedbush
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€127.63
Performance (%)
13.38%
Price
09:37
€121.60
Summary
This prediction is currently active. The prediction currently has a performance of 13.38%. This prediction currently runs until 13.09.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -3.209% | -3.209% |
iShares Core DAX® | 0.805% | 2.118% |
iShares Nasdaq 100 | 1.995% | 4.071% |
iShares Nikkei 225® | 1.264% | -2.374% |
iShares S&P 500 | 1.637% | 2.287% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Wedbush from $120.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-1.78%
09:37
09:37